Kato K - Search Results

1

Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.

Kang YK, Chen LT, Ryu MH, Oh DY, Oh SC, Chung HC, Lee KW, Omori T, Shitara K, Sakuramoto S, Chung IJ, Yamaguchi K, Kato K, Sym SJ, Kadowaki S, Tsuji K, Chen JS, Bai LY, Oh SY, Choda Y, Yasui H, Takeuchi K, Hirashima Y, Hagihara S, Boku N. Kang YK, et al. Among authors: kato k. Lancet Oncol. 2022 Feb;23(2):234-247. doi: 10.1016/S1470-2045(21)00692-6. Epub 2022 Jan 11. Lancet Oncol. 2022. PMID: 35030335 Clinical Trial.

2

Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.

Matsubara J, Yamada Y, Hirashima Y, Takahari D, Okita NT, Kato K, Hamaguchi T, Shirao K, Shimada Y, Shimoda T. Matsubara J, et al. Among authors: kato k. Clin Cancer Res. 2008 May 15;14(10):3022-9. doi: 10.1158/1078-0432.CCR-07-1898. Clin Cancer Res. 2008. PMID: 18483367

3

Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer.

Matsubara J, Yamada Y, Nakajima TE, Kato K, Hamaguchi T, Shirao K, Shimada Y, Shimoda T. Matsubara J, et al. Among authors: kato k. Oncology. 2008;74(1-2):76-83. doi: 10.1159/000139127. Epub 2008 Jun 11. Oncology. 2008. PMID: 18544998 Clinical Trial.

4

A phase i study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel (FLTAX) as first-line therapy for advanced gastric cancer.

Matsubara J, Shimada Y, Takashima A, Takahari D, Hirashima Y, Okita NT, Nakajima TE, Kato K, Hamaguchi T, Yamada Y, Shirao K. Matsubara J, et al. Among authors: kato k. Jpn J Clin Oncol. 2008 Aug;38(8):540-6. doi: 10.1093/jjco/hyn062. Epub 2008 Jul 15. Jpn J Clin Oncol. 2008. PMID: 18628316 Clinical Trial.

5

Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.

Takahari D, Yamada Y, Okita NT, Honda T, Hirashima Y, Matsubara J, Takashima A, Kato K, Hamaguchi T, Shirao K, Shimada Y, Shimoda T. Takahari D, et al. Among authors: kato k. Oncology. 2009;76(1):42-8. doi: 10.1159/000178164. Epub 2008 Nov 26. Oncology. 2009. PMID: 19033715

6

Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer.

Hirashima Y, Yamada Y, Matsubara J, Takahari D, Okita N, Takashima A, Kato K, Hamaguchi T, Shirao K, Shimada Y, Taniguchi H, Shimoda T. Hirashima Y, et al. Among authors: kato k. Cancer Sci. 2009 Feb;100(2):310-5. doi: 10.1111/j.1349-7006.2008.01020.x. Cancer Sci. 2009. PMID: 19068081 Free article.

7

A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.

Nakajima TE, Ura T, Ito Y, Kato K, Minashi K, Nihei K, Hironaka S, Boku N, Kagami Y, Muro K. Nakajima TE, et al. Among authors: kato k. Jpn J Clin Oncol. 2009 Jan;39(1):37-42. doi: 10.1093/jjco/hyn125. Jpn J Clin Oncol. 2009. PMID: 19103671 Clinical Trial.

8

Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine.

Ono M, Shirao K, Takashima A, Morizane C, Okita N, Takahari D, Hirashima Y, Eguchi-Nakajima T, Kato K, Hamaguchi T, Yamada Y, Shimada Y. Ono M, et al. Among authors: kato k. Gastric Cancer. 2008;11(4):201-5. doi: 10.1007/s10120-008-0484-5. Epub 2009 Jan 8. Gastric Cancer. 2008. PMID: 19132481

9

A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors.

Shirao K, Yoshino T, Boku N, Kato K, Hamaguchi T, Yasui H, Yamamoto N, Tanigawara Y, Nolting A, Yoshino S. Shirao K, et al. Among authors: kato k. Cancer Chemother Pharmacol. 2009 Aug;64(3):557-64. doi: 10.1007/s00280-008-0904-6. Epub 2009 Jan 24. Cancer Chemother Pharmacol. 2009. PMID: 19169687 Clinical Trial.

10

Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experience.

Hashimoto K, Mayahara H, Takashima A, Nakajima TE, Kato K, Hamaguchi T, Ito Y, Yamada Y, Kagami Y, Itami J, Shimada Y. Hashimoto K, et al. Among authors: kato k. J Cancer Res Clin Oncol. 2009 Aug;135(8):1117-23. doi: 10.1007/s00432-009-0553-0. Epub 2009 Feb 10. J Cancer Res Clin Oncol. 2009. PMID: 19205735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,669 results

Search Page